LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

LLY

1,103

-2.23%↓

JNJ

225.18

-2.6%↓

ABBV

217.96

-0.27%↓

UNH

378.65

-0.98%↓

MRK

118.6

-1.13%↓

Home・Lista de Ações・Intuitive Surgical Inc

Intuitive Surgical Inc

Fechado

SetorSaúde

424.07 0.17

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

419.65

Máximo

425.8

Indicadores-chave
By Trading Economics
Rendimento	22M 822M
Vendas	-95M 2.8B
P/E Médio do Setor	53.168 50.102
EPS	2.5
Margem de lucro	29.648
Funcionários	17,021
EBITDA	-230M 855M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+34.46% upside

Dividendos
By Dow Jones
Próximos Ganhos	21 de jul. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-10B 155B
Abertura anterior	423.9
Fecho anterior	424.07

Sentimento de Notícias

By Acuity

39%

61%

112 / 344 Ranking em Healthcare

Intuitive Surgical Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de abr. de 2026, 15:47 UTC

Grandes Movimentos do Mercado

Intuitive Surgical Shares Rise After 1Q Beat

21 de abr. de 2026, 20:54 UTC

Ganhos

Intuitive Surgical Posts Higher 1Q Sales, Profit

22 de abr. de 2026, 11:27 UTC

Ganhos

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21 de abr. de 2026, 21:14 UTC

Ganhos

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

21 de abr. de 2026, 20:38 UTC

Ganhos

Intuitive Surgical 1Q Rev $2.77B >ISRG

21 de abr. de 2026, 20:38 UTC

Ganhos

Intuitive Surgical 1Q Net $821.5M >ISRG

21 de abr. de 2026, 20:38 UTC

Ganhos

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 431.00 >ISRG

21 de abr. de 2026, 20:38 UTC

Ganhos

Intuitive Surgical 1Q Adj EPS $2.50 >ISRG

21 de abr. de 2026, 20:38 UTC

Ganhos

Intuitive Surgical 1Q EPS $2.28 >ISRG

21 de abr. de 2026, 20:14 UTC

Ganhos

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of About 13.5% to 15.5%

21 de abr. de 2026, 20:14 UTC

Ganhos

Intuitive Surgical 1Q Rev $2.77B

21 de abr. de 2026, 20:13 UTC

Ganhos

Intuitive Surgical 1Q Adj EPS $2.50

21 de abr. de 2026, 20:12 UTC

Ganhos

Intuitive Surgical 1Q EPS $2.28

14 de abr. de 2026, 14:13 UTC

Ganhos

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

14 de abr. de 2026, 12:57 UTC

Ganhos

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

17 de fev. de 2026, 14:48 UTC

Ganhos

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

23 de jan. de 2026, 16:07 UTC

Ganhos

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 de jan. de 2026, 12:58 UTC

Ganhos

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 de jan. de 2026, 21:10 UTC

Ganhos

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Net $794.8M >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 de out. de 2025, 12:38 UTC

Ganhos

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 de out. de 2025, 12:01 UTC

Ganhos

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 de out. de 2025, 15:42 UTC

Ganhos

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 de out. de 2025, 12:34 UTC

Ganhos

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

Comparação entre Pares

Variação de preço

Intuitive Surgical Inc Previsão

Preço-alvo

By TipRanks

34.46% parte superior

Previsão para 12 meses

Média 569.61 USD 34.46%

Máximo 670 USD

Mínimo 451 USD

Com base em 20 analistas de Wall Street que oferecem metas de preço de 12 meses para Intuitive Surgical Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

20 ratings

Comprar

Manter

Vender

Com base em 20 analistas que deram avaliações de ações para Intuitive Surgical Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

112 / 344 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.